Skip to content

ClearPoint Neuro CLPT Market capitalization

Market capitalization at other companies

Abbott logo
AbbottABT
$178.41B-22.5%
Boston Scientific logo
Boston ScientificBSX
$93.26B-37.5%
IAR
Integra LifeSciencesIART
$734.17M-56.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$17.69B-21.5%
Medtronic logo
MedtronicMDT
$103.96B-3.8%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$442.72M+10.6%

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Computed from the period-end share price: $269.94M.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's market capitalization?
ClearPoint Neuro (CLPT) reported market capitalization of $269.94M in Q1 2026.
How has ClearPoint Neuro's market capitalization changed year-over-year?
ClearPoint Neuro's market capitalization decreased by 17.8% year-over-year, from $328.55M to $269.94M.
What is the long-term trend for ClearPoint Neuro's market capitalization?
Over 5 years (2020 to 2025), ClearPoint Neuro's market capitalization has grown at a 1.6% compound annual growth rate (CAGR), from $375.63M to $406.96M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.